212 related articles for article (PubMed ID: 8472853)
21. Response of rat ventral prostate to a new and novel 5 alpha-reductase inhibitor.
Brooks JR; Baptista EM; Berman C; Ham EA; Hichens M; Johnston DB; Primka RL; Rasmusson GH; Reynolds GF; Schmitt SM; Arth GE
Endocrinology; 1981 Sep; 109(3):830-6. PubMed ID: 7262023
[No Abstract] [Full Text] [Related]
22. The effect of a 5 alpha-reductase inhibitor on androgen-mediated growth of the dog prostate.
Wenderoth UK; George FW; Wilson JD
Endocrinology; 1983 Aug; 113(2):569-73. PubMed ID: 6872940
[TBL] [Abstract][Full Text] [Related]
23. Effects of perinatal exposure to flutamide on sex hormone responsiveness in F1 male rats.
Miyata K; Yabushita S; Sano M; Miyashita K; Okuno Y; Matsuo M
J Toxicol Sci; 2003 Aug; 28(3):149-63. PubMed ID: 12974607
[TBL] [Abstract][Full Text] [Related]
24. 12. Androgens: Pharmacodynamics and antagonists. Biochemical and biological studies with 4-aza-steroidal 5 alpha-reductase inhibitors.
Liang T; Rasmusson GH; Brooks JR
J Steroid Biochem; 1983 Jul; 19(1A):385-90. PubMed ID: 6887871
[TBL] [Abstract][Full Text] [Related]
25. Consideration of the use of 17 beta-N,N-diethylcarbamoyl-4-methyl-4-aza-5- alpha-androstan-3-one (4MA), a 5 alpha-reductase inhibitor, in prostate cancer therapy.
Geldof AA; Meulenbroek MF; Dijkstra I; Bohlken S; Rao BR
J Cancer Res Clin Oncol; 1992; 118(1):50-5. PubMed ID: 1729259
[TBL] [Abstract][Full Text] [Related]
26. Androgen-independent effects of prolactin on the different lobes of the immature rat prostate.
Reiter E; Lardinois S; Klug M; Sente B; Hennuy B; Bruyninx M; Closset J; Hennen G
Mol Cell Endocrinol; 1995 Jul; 112(1):113-22. PubMed ID: 7589778
[TBL] [Abstract][Full Text] [Related]
27. Nonsteroid antiandrogen inhibiting effect on testosterone metabolism in rat prostate and liver.
Reznikov A; Korpacheva T
Endocrinol Exp; 1990 Dec; 24(4):437-47. PubMed ID: 2096078
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of 5alpha-reductase in rat prostate reveals differential regulation of androgen-response gene expression by testosterone and dihydrotestosterone.
Dadras SS; Cai X; Abasolo I; Wang Z
Gene Expr; 2001; 9(4-5):183-94. PubMed ID: 11444528
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the effects of the 5 alpha-reductase inhibitor finasteride and the antiandrogen flutamide on prostate and genital differentiation: dose-response studies.
Imperato-McGinley J; Sanchez RS; Spencer JR; Yee B; Vaughan ED
Endocrinology; 1992 Sep; 131(3):1149-56. PubMed ID: 1324152
[TBL] [Abstract][Full Text] [Related]
30. Adrenal steroid precursors exert potent androgenic action in the hamster sebaceous glands of flank organs and ears.
Chen C; Belanger A; Labrie F
Endocrinology; 1996 May; 137(5):1752-7. PubMed ID: 8612511
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of 5 alpha-reductase, receptor binding, and nuclear uptake of androgens in the prostate by a 4-methyl-4-aza-steroid.
Liang T; Heiss CE
J Biol Chem; 1981 Aug; 256(15):7998-8005. PubMed ID: 7263637
[TBL] [Abstract][Full Text] [Related]
32. Quantification of antiandrogen effect determined by Lightcycler technology.
Nellemann C; Vinggaard AM; Dalgaard M; Hossaini A; Larsen JJ
Toxicology; 2001 May; 163(1):29-38. PubMed ID: 11376863
[TBL] [Abstract][Full Text] [Related]
33. Androgenic activity of dehydroepiandrosterone and androstenedione in the rat ventral prostate.
Labrie C; Belanger A; Labrie F
Endocrinology; 1988 Sep; 123(3):1412-7. PubMed ID: 2969802
[TBL] [Abstract][Full Text] [Related]
34. Androgen metabolism in the prostate of the finasteride-treated, adult rat: a possible explanation for the differential action of testosterone and 5 alpha-dihydrotestosterone during development of the male urogenital tract.
George FW
Endocrinology; 1997 Mar; 138(3):871-7. PubMed ID: 9048585
[TBL] [Abstract][Full Text] [Related]
35. Modulation of gene expression by androgen and oestrogens in the testis and prostate of the adult rat following androgen withdrawal.
Turner KJ; Morley M; MacPherson S; Millar MR; Wilson JA; Sharpe RM; Saunders PT
Mol Cell Endocrinol; 2001 Jun; 178(1-2):73-87. PubMed ID: 11403897
[TBL] [Abstract][Full Text] [Related]
36. Androgens regulate brain aromatase activity in adult male rats through a receptor mechanism.
Roselli CE; Resko JA
Endocrinology; 1984 Jun; 114(6):2183-9. PubMed ID: 6723579
[TBL] [Abstract][Full Text] [Related]
37. Action of prolactin in regressing prostate: independent of action mediated by androgen receptors.
Assimos D; Smith C; Lee C; Grayhack JT
Prostate; 1984; 5(6):589-95. PubMed ID: 6494057
[TBL] [Abstract][Full Text] [Related]
38. In vitro effects of an aromatase inhibitor on 5 alpha-reductase activity in human hypertrophic prostatic tissue.
Zoppi S; Cocconi M; Natali A; Costantini A; Serio M; Martini L; Motta M
J Clin Endocrinol Metab; 1986 Jul; 63(1):269-71. PubMed ID: 2423549
[TBL] [Abstract][Full Text] [Related]
39. Prostatic involution in rats induced by a novel 5 alpha-reductase inhibitor, SK&F 105657: role for testosterone in the androgenic response.
Lamb JC; English H; Levandoski PL; Rhodes GR; Johnson RK; Isaacs JT
Endocrinology; 1992 Feb; 130(2):685-94. PubMed ID: 1733716
[TBL] [Abstract][Full Text] [Related]
40. Effect of castration, DES, flutamide, and the 5 alpha-reductase inhibitor, MK-906, on the growth of the Dunning rat prostatic carcinoma, R-3327.
Brooks JR; Berman C; Nguyen H; Prahalada S; Primka RL; Rasmusson GH; Slater EE
Prostate; 1991; 18(3):215-27. PubMed ID: 1850515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
